Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Mesh:France"" wg kryterium: Temat


Tytuł :
[Dihydropyrimidine dehydrogenase deficiency screening for management of patients receiving a fluoropyrimidine: Results of two national practice surveys addressed to clinicians and biologists].
Intérêts et limites de la recherche du déficit en dihydropyrimidine déshydrogénase dans le suivi des patients traités par fluoropyrimidines : résultats de deux enquêtes nationales de pratiques réalisées auprès des médecins et des biologistes
Autorzy :
Loriot, Marie-Anne
Masskouri, Fadil
Carni, Paolo
Le Malicot, Karine
Seitz, Jean-François
Michel, Pierre
Legoux, Jean-Louis
Bouche, Olivier
André, Thierry
Faroux, Roger
Delaloge, Suzette
Malka, David
Guigay, Joël
Thariat, Juliette
Thomas, Fabienne
Barin-Le-Guellec, Chantal
Ciccolini, Joseph
Boyer, Jean-Christophe
Etienne-Grimaldi, Marie-Christine
Pokaż więcej
Temat :
DPD
Dihydropyrimidine dehydrogenase
Dihydropyrimidine déshydrogénase
Dépistage
Enquête
Fluoropyrimidine
Screening
Surveys
Toxicity
Toxicité
MESH: Antimetabolites, Antineoplastic
MESH: Antineoplastic Combined Chemotherapy Protocols
MESH: Female
MESH: Fluorouracil
MESH: France
MESH: Genotype
MESH: Health Care Surveys
MESH: Humans
MESH: Oncologists
MESH: Otorhinolaryngologic Neoplasms
MESH: Pharmacovigilance
MESH: Practice Guidelines as Topic
MESH: Pyrimidines
MESH: Reimbursement Mechanisms
MESH: Biology
MESH: Biomedical Research
MESH: Breast Neoplasms
MESH: Capecitabine
MESH: Digestive System Neoplasms
MESH: Dihydropyrimidine Dehydrogenase Deficiency
[SDV]Life Sciences [q-bio]
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Źródło :
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
Tytuł :
[Dihydropyrimidine dehydrogenase deficiency screening for management of patients receiving a fluoropyrimidine: Results of two national practice surveys addressed to clinicians and biologists].
Intérêts et limites de la recherche du déficit en dihydropyrimidine déshydrogénase dans le suivi des patients traités par fluoropyrimidines : résultats de deux enquêtes nationales de pratiques réalisées auprès des médecins et des biologistes
Autorzy :
Loriot, Marie-Anne
Masskouri, Fadil
Carni, Paolo
Le Malicot, Karine
Seitz, Jean-François
Michel, Pierre
Legoux, Jean-Louis
Bouche, Olivier
André, Thierry
Faroux, Roger
Delaloge, Suzette
Malka, David
Guigay, Joël
Thariat, Juliette
Thomas, Fabienne
Barin-Le-Guellec, Chantal
Ciccolini, Joseph
Boyer, Jean-Christophe
Etienne-Grimaldi, Marie-Christine
Pokaż więcej
Temat :
DPD
Dihydropyrimidine dehydrogenase
Dihydropyrimidine déshydrogénase
Dépistage
Enquête
Fluoropyrimidine
Screening
Surveys
Toxicity
Toxicité
MESH: Antimetabolites, Antineoplastic
MESH: Antineoplastic Combined Chemotherapy Protocols
MESH: Female
MESH: Fluorouracil
MESH: France
MESH: Genotype
MESH: Health Care Surveys
MESH: Humans
MESH: Oncologists
MESH: Otorhinolaryngologic Neoplasms
MESH: Pharmacovigilance
MESH: Practice Guidelines as Topic
MESH: Pyrimidines
MESH: Reimbursement Mechanisms
MESH: Biology
MESH: Biomedical Research
MESH: Breast Neoplasms
MESH: Capecitabine
MESH: Digestive System Neoplasms
MESH: Dihydropyrimidine Dehydrogenase Deficiency
[SDV]Life Sciences [q-bio]
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Źródło :
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
Tytuł :
[Dihydropyrimidine dehydrogenase deficiency screening for management of patients receiving a fluoropyrimidine: Results of two national practice surveys addressed to clinicians and biologists].
Intérêts et limites de la recherche du déficit en dihydropyrimidine déshydrogénase dans le suivi des patients traités par fluoropyrimidines : résultats de deux enquêtes nationales de pratiques réalisées auprès des médecins et des biologistes
Autorzy :
Loriot, Marie-Anne
Masskouri, Fadil
Carni, Paolo
Le Malicot, Karine
Seitz, Jean-François
Michel, Pierre
Legoux, Jean-Louis
Bouche, Olivier
André, Thierry
Faroux, Roger
Delaloge, Suzette
Malka, David
Guigay, Joël
Thariat, Juliette
Thomas, Fabienne
Barin-Le-Guellec, Chantal
Ciccolini, Joseph
Boyer, Jean-Christophe
Etienne-Grimaldi, Marie-Christine
Pokaż więcej
Temat :
DPD
Dihydropyrimidine dehydrogenase
Dihydropyrimidine déshydrogénase
Dépistage
Enquête
Fluoropyrimidine
Screening
Surveys
Toxicity
Toxicité
MESH: Antimetabolites, Antineoplastic
MESH: Antineoplastic Combined Chemotherapy Protocols
MESH: Female
MESH: Fluorouracil
MESH: France
MESH: Genotype
MESH: Health Care Surveys
MESH: Humans
MESH: Oncologists
MESH: Otorhinolaryngologic Neoplasms
MESH: Pharmacovigilance
MESH: Practice Guidelines as Topic
MESH: Pyrimidines
MESH: Reimbursement Mechanisms
MESH: Biology
MESH: Biomedical Research
MESH: Breast Neoplasms
MESH: Capecitabine
MESH: Digestive System Neoplasms
MESH: Dihydropyrimidine Dehydrogenase Deficiency
[SDV]Life Sciences [q-bio]
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Źródło :
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
Tytuł :
[Dihydropyrimidine dehydrogenase deficiency screening for management of patients receiving a fluoropyrimidine: Results of two national practice surveys addressed to clinicians and biologists].
Intérêts et limites de la recherche du déficit en dihydropyrimidine déshydrogénase dans le suivi des patients traités par fluoropyrimidines : résultats de deux enquêtes nationales de pratiques réalisées auprès des médecins et des biologistes
Autorzy :
Loriot, Marie-Anne
Masskouri, Fadil
Carni, Paolo
Le Malicot, Karine
Seitz, Jean-François
Michel, Pierre
Legoux, Jean-Louis
Bouche, Olivier
André, Thierry
Faroux, Roger
Delaloge, Suzette
Malka, David
Guigay, Joël
Thariat, Juliette
Thomas, Fabienne
Barin-Le-Guellec, Chantal
Ciccolini, Joseph
Boyer, Jean-Christophe
Etienne-Grimaldi, Marie-Christine
Pokaż więcej
Temat :
DPD
Dihydropyrimidine dehydrogenase
Dihydropyrimidine déshydrogénase
Dépistage
Enquête
Fluoropyrimidine
Screening
Surveys
Toxicity
Toxicité
MESH: Antimetabolites, Antineoplastic
MESH: Antineoplastic Combined Chemotherapy Protocols
MESH: Female
MESH: Fluorouracil
MESH: France
MESH: Genotype
MESH: Health Care Surveys
MESH: Humans
MESH: Oncologists
MESH: Otorhinolaryngologic Neoplasms
MESH: Pharmacovigilance
MESH: Practice Guidelines as Topic
MESH: Pyrimidines
MESH: Reimbursement Mechanisms
MESH: Biology
MESH: Biomedical Research
MESH: Breast Neoplasms
MESH: Capecitabine
MESH: Digestive System Neoplasms
MESH: Dihydropyrimidine Dehydrogenase Deficiency
[SDV]Life Sciences [q-bio]
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
Źródło :
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
Tytuł :
Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage
Autorzy :
Cossais, Sabrina
Schwarzinger, Michaël
Pol, Stanislas
Fontaine, Hélène
Larrey, Dominique
Pageaux, Georges-Philippe
Canva, Valérie
Mathurin, Philippe
Yazdanpanah, Yazdan
Deuffic-Burban, Sylvie
Pokaż więcej
Temat :
MESH: Hepatitis C, Chronic/psychology
MESH: Male
Pharmaceutics
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
MESH: Cross-Sectional Studies
Population Groupings
Fatigue
Physicians
Children
Public and Occupational Health
France
MESH: Female
MESH: Adult
Health Care Providers
Biology and Life Sciences
Addiction
Patients
Age Groups
MESH: Health Surveys
MESH: Quality of Life/psychology
MESH: Middle Aged
MESH: Comorbidity
Science
Fibrosis
Research Article
Diagnostic Medicine
MESH: Aged
Signs and Symptoms
Substance-Related Disorders
Pathology and Laboratory Medicine
Professions
Geographical locations
Mental Health and Psychiatry
MESH: Severity of Illness Index
Psychology
Alcoholism
MESH: Young Adult
People and Places
MESH: France
Medical Personnel
Europe
Health Care
Medical Doctors
Drug Therapy
Developmental Biology
MESH: Humans
Medicine
MESH: Disease Progression
Families
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
Social Sciences
European Union
Medicine and Health Sciences
Źródło :
PLoS ONE, Vol 14, Iss 5, p e0215596 (2019)
PLoS ONE, Public Library of Science, 2019, 14 (5), pp.e0215596. ⟨10.1371/journal.pone.0215596⟩
Tytuł :
Storage mite concentrations are underestimated compared to house dust mite concentrations
Storage mite concentrations are underestimated compared to house dust mite concentrations.
Autorzy :
Reboux, Gabriel
Valot, Benoit
Rocchi, Steffi
Scherer, Emeline
Roussel, Sandrine
Millon, Laurence
Pokaż więcej
Temat :
Allergy
Dwellings
Electrostatic dust collector
House dust mites
Storage mites
qPCR
MESH: Acaridae
MESH: Animal Distribution
MESH: Mites
MESH: Population Density
MESH: Real-Time Polymerase Chain Reaction
MESH: Animals
MESH: Dermatophagoides farinae
MESH: Dermatophagoides pteronyssinus
MESH: Dust
MESH: France
MESH: Housing
MESH: Humans
MESH: Hypersensitivity
[SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health
Źródło :
Experimental and Applied Acarology
Experimental and Applied Acarology, Springer Verlag, 2019, 77 (4), pp.511-525. ⟨10.1007/s10493-019-00376-2⟩

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies